Verition Fund Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$754K	Buy	53,925 +36,288	+206%	+$507K	﹤0.01%	2019
2025 Q1	$238K	Buy	+17,637	New	+$238K	﹤0.01%	2323
2023 Q3	–	Sell	-13,300	Closed	-$316K	–	2295
2023 Q2	$316K	Buy	13,300 +300	+2%	+$7.14K	﹤0.01%	1316
2023 Q1	$331K	Buy	+13,000	New	+$331K	﹤0.01%	1342